Crystal structures of human antibodies: A detailed and unfinished tapestry of immunoglobulin gene products

Journal of Molecular Recognition

Volumn 15, Issue 5, 2002, Pages 248-259

  Ramsland, Paul A ^a   Farrugia, William ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Antibody crystallography; Antibody engineering; Antibody structure; Human antibodies; Humanization

Indexed keywords

PARAPROTEIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ANTIBODY STRUCTURE; CRYSTAL STRUCTURE; IMMUNE RESPONSE; IMMUNOGLOBULIN GENE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; ANIMAL; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; PROTEIN ENGINEERING; REVIEW; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY DIVERSITY; BINDING SITES, ANTIBODY; CRYSTALLOGRAPHY, X-RAY; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS; MICE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY;

EID: 0036760452     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.585     Document Type: Review

References (102)

1. Al-Lazikani B, Lesk AM, Chothia C. 1997. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273: 927-948.
2. Altschuh D, Vix O, Rees B, Thierry J-C. 1992. A conformation of Cyclosporin A in aqueous environment revealed by the X-ray structure of a Cyclosporin-Fab complex. Science 256: 92-94.
3. Amit AG, Mariuzza RA, Philips SEV, Poljak RJ. 1986. Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233: 747-753.
4. Bolt S, Routledge E, Lloyd I, Chatenoud L, Pope H, Gorman SD, Clark M, Waldmann H. 1993. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur. J. Immunol. 23: 403-411.
5. Boulianne GL, Hozumi N, Shulman MJ. 1984. Production of functional chimaeric mouse/human antibody. Nature 312: 643-646.
6. Boyd PN, Lines AC, Patel AK. 1995. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1 H. Mol. Immunol. 32: 1311-1318.
7. Brown M, Schumacher MA, Wiens GD, Brennan RG, Rittenberg MB. 2000. The structural basis of repertoire shift in an immune response to phosphocholine. J. Exp. Med. 191: 2101-2112.
8. Brüggemann M, Winter G, Waldmann H, Neuberger MS. 1989. The immunogenicity of chimeric antibodies. J. Exp. Med. 170: 2153-2157.
9. Brüggemann M, Spicer C, Buluwela L, Rosewell I, Barton S, Surani MA, Rabbitts TH. 1991. Human antibody production in transgenic mice: Expression from 100 kb of the human Ig H locus. Eur. J. Immunol. 21: 1323-1326.
10. Cauerhff A, Braden BC, Carvalho JG, Aparicio R, Polikarpov I, Leoni J, Goldbaum FA. 2000. Three-dimensional structure of the Fab from a human IgM cold agglutinin. J. Immunol. 165: 6422-6428.
11. Chacko S, Padlan EA, Portolano S, McLachlan SM, Rapoport B. 1996. Structural studies of human autoantibodies. Crystal structure of a thyroid peroxidase autoantibody Fab. J. Biol. Chem. 271: 12191-12198.
12. H segments. J. Mol. Biol. 227: 799-817.
13. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. 1991. Making antibody fragments using phage display libraries. Nature 352: 624-628.
14. Clark M. 2000. Antibody humanization: A case of the 'Emperor's new clothes'? Immunol. Today 21: 397-402.
15. Co MS, Deschamps M, Whitley RJ, Queen C. 1991. Humanized antibodies for antiviral therapy. Proc. Natl Acad. Sci. USA 88: 2869-2873.
16. Colman PM, Laver WG, Varghese JN, Tulloch PA, Air GM, Webster RG. 1987. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 326: 358-363.
17. Corper AL, Sohi MK, Bonagura VR, Steinitz M, Jefferis R, Feinstein A, Beale D, Taussig MJ, Sutton BJ. 1997. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struct. Biol. 4: 374-381.
18. Deisenhofer J, Colman PM, Epp O, Huber R. 1976. Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 Å resolution. Hoppe-Seyler's Z. Physiol. Chem. 357: 1421-1434.
19. Deutsch HF, Suzuki T. 1971. A crystalline γG1 human monoclonal protein with an extensive H-chain deletion. Ann. NY Acad. Sci. 190: 472-486.
20. Edmundson AB, Wood MK, Schiffer M, Hardman KD, Ainsworth CF, Ely KR, Deutsch HF. 1970. A crystallographic investigation of a human IgG immunoglobulin. J. Biol. Chem. 245: 2763-2764.
21. Edmundson AB, Schiffer M, Wood MK, Hardman KD, Ely KR, Ainsworth CF. 1971. Crystallographic studies of an IgG immunoglobulin and the Bence-Jones protein from one patient. Cold Spring Harbor Symp. Quant. Biol. 36: 427-432.
22. Edmundson AB, Ely KR, Girling RL, Abola EE, Schiffer M, Westholm FA. 1974a. Structure and binding properties of a λ-type Bence-Jones dimer. In Progress in Immunology II, Brent L, Holborow J (eds). North-Holland: Amsterdam; 103-113.
23. Edmundson AB, Ely KR, Girling RL, Abola EE, Schiffer M, Westholm FA, Fausch MD, Deutsch HF. 1974b. Binding of 2,4-dinitrophenyl compounds and other small molecules to a crystalline λ-type Bence-Jones dimer. Biochemistry 13: 3816-3827.
24. Edmundson AB, Ely KR, Abola EE, Schiffer M, Panagiotopoulos N. 1975. Rotational allomerism and divergent evolution of domains in immunoglobulin light chains. Biochemistry 14: 3953-3961.
25. Edmundson AB, Guddat LW, Rosauer RA, Andersen KN, Shan L, Fan Z-C. 1995. Three-dimensional aspects of IgG structure and function. In The Antibodies, Zanetti M, Capra JD (eds). Harvard Academic: Luxembourg; 41-100.
26. Edmundson AB, Shan L, Fan Z, Guddat LW, Hanson BL, Andersen KN. 1996. Crystallographic analysis of antigen-antibody complexes: End-on insertion of ligands in antibodies-CDR3 loops as arbiter. Meth. A Compan. Meth. Enzymol. 9: 542-558.
27. Ely KR, Colman PM, Abola EE, Hess AC, Peabody DS, Parr DM, Connell GE, Laschinger CA, Edmundson AB. 1978. Mobile Fc region in the Zie IgG2 cryoglobulin: Comparison of crystals of the F(ab′)2 fragment and the intact immunoglobulin. Biochemistry 17: 820-823.
28. Ely KR, Herron JN, Harker M, Edmundson AB. 1989. Three-dimensional structure of a light chain dimer crystallized in water; conformational flexibility of a molecule in two crystal forms. J. Mol. Biol. 210: 601-615.
29. Faber C, Shan L, Fan Z, Guddat LW, Furebring C, Ohlin M, Borrebaeck CAK, Edmundson AB. 1998. Three-dimensional structure of a human Fab with high affinity for tetanus toxoid. Immunotech 3: 253-270.
30. Fan Z-C, Shan L, Guddat LW, He XM, Gray WR, Raison RL, Edmundson AB. 1992. Three-dimensional structure of an Fv from a human IgM immunoglobulin. J. Mol. Biol. 228: 188-207.
31. Fan Z, Shan L, Goldsteen BZ, Guddat LW, Thakur A, Landolfi NF, Co MS, Vasquez M, Queen C, Ramsland PA, Edmundson AB. 1999. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-γ-interferon antibody. J. Mol. Recognit. 12: 19-32.
32. Feinstein A, Rowe AJ. 1965. Molecular mechanism of formation of an antigen-antibody complex. Nature 205: 147-149.
33. Fett JW, Deutsch HF, Smithies O. 1973. Hinge-region deletion localized in the IgG1-globulin Mcg. Immunochemistry 10: 115-118.
34. Foote J, Winter G. 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224: 487-499
35. Furey W Jr, Wang B-C, Yoo CS, Sax M. 1983. Structure of a novel Bence-Jones protein (Rhe) fragment at 1.6 Å resolution. J. Mol. Biol. 167: 661-692.
36. Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, Silverman GJ. 2000. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl Acad. Sci. USA 97: 5399-5404.
37. Green LL, Hardy MC, Maynard-Currie CE, Tsuda H, Louie DM, Mendez MJ, Abderrahim H, Noguchi M, Smith DH, Zeng Y, et al. 1994. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. 7: 13-21.
38. Guddat LW, Herron JN, Edmundson AB. 1993. Three-dimensional structure of a human immunoglobulin with a hinge deletion. Proc. Natl Acad. Sci. 90: 4271-4275.
39. Guddat LW, Shan L, Anchin JM, Linthicum DS, Edmundson AB. 1994. Local and transmitted conformational changes on complexation of an anti-sweetener Fab. J. Mol. Biol. 236: 247-274.
40. Guddat LW, Shan L, Broomell C, Ramsland PA, Fan Z, Anchin JM, Linthicum DS, Edmundson AB. 2000. The three-dimensional structure of a complex of a murine Fab (NC10.14) with a potent sweetener (NC174): An illustration of structural diversity in antigen recognition by immunoglobulins. J. Mol. Biol. 302: 853-872.
41. Harris LJ, Larson SB, Hasel KW, Day J, Greenwood A, McPherson A. 1992. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature 360: 369-372.
42. Harris LJ, Skaletsky E, McPherson A. 1998. Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 275: 861-872.
43. He XM, Rüker F, Casale E, Carter DC. 1992. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 89: 7154-7158.
44. Herron JN, He XM, Ballard DW, Blier PR, Pace PE, Bothwell ALM, Voss EW Jr, Edmundson AB. 1991. An autoantibody to single-stranded DNA: Comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex. Proteins Struct. Funct. Genet. 11: 159-175.
45. Hsu E, Steiner LA. 1992. Primary structure of immunoglobulins through evolution. Curr. Opin. Struct. Biol. 2: 422-431.
46. Huang DB, Ainsworth CF, Stevens FJ, Schiffer M. 1996. Three quaternary structures for a single protein. Proc. Natl Acad. Sci. USA 93: 7017-7021.
47. Huang DB, Chang CH, Ainsworth C, Johnson G, Solomon A, Stevens FJ, Schiffer M. 1997. Variable domain structure of kappa IV human light chain Len: High homology to the murine light chain McPC603. Mol. Immunol. 34: 1291-1301.
48. Hunkapiller T, Hood L. 1989. Diversity of the immunoglobulin gene superfamily. Adv. Immunol. 44: 1-63.
49. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321: 522-525.
50. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. 1991. Sequences of Proteins of Immunological Interest, 5th Edn. Public Health Service, US Department of Health and Human Services, National Institutes of Health: Bethesda, MD.
51. Klein M, Haeffner-Cavaillon N, Isenman DE, Rivat C, Navia MA, Davies DR, Dorrington KJ. 1981. Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc. Natl Acad. Sci. USA 78: 524-528.
52. Kohler G, Milstein C. 1975. Continuous culture of fused cells secreting specific antibody of predefined specificity. Nature 256: 495-497.
53. Koradi R, Billeter M, Wuthrich K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
54. Kratzin HD, Palm W, Stangel M, Schmidt WE, Friedrich J, Hilschmann N. 1989. Die Primärstruktur des kristallisierbaren monoklonalen Immunoglobulins Ig1 Kol. II. Aminosäuresequenz der L-Kette, Γ-Type, Subgruppe I. Biol. Chem. Hoppe-Seyler 370: 263-272.
55. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659.
56. Marchalonis JJ, Schluter SF. 1989. Evolution of variable and constant domains and joining segments of rearranging immunoglobulins. FASEB J. 3: 2469-2479.
57. Marquart M, Deisenhofer J, Huber R, Palm W. 1980. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 Å and 1.9 Å resolution. J. Mol. Biol. 141: 369-391.
58. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. 1990. Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348: 552-554.
59. Meltzer M, Franklin EC. 1966. Cryoglobulinemia - A study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am. J. Med. 40: 828-836.
60. Mendez MJ, Green LL, Corvalan JR, Jia XC, Maynard-Currie CE, Yang XD, Gallo ML, Louie DM, Lee DV, Erickson KL, Luna J, Roy CM, Abderrahim H, Kirschenbaum F, Noguchi M, Smith DH, Fukushima A, Hales JF, Klapholz S, Finer MH, Davis CG, Zsebo KM, Jakobovits A. 1997. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat. Genet. 15: 146-156.
61. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. 1984. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc. Natl Acad. Sci. USA 81: 6851-6855.
62. Newkirk MM, Edmundson A, Wistar R Jr, Klapper DG, Capra JD. 1987. A new protocol to digest human IgM with papain that results in homogeneous Fab preparations that can be routinely crystallized. Hybridoma 6: 453-460.
63. Nezlin R. 1990. Internal movements in immunoglobulin molecules. Adv. Immunol. 48: 1-40.
64. Nezlin R. 1998. The Immunoglobulins: Structure and Function. Academic Press: New York.
65. Nilson BH, Solomon A, Bjorck L, Akerstrom B. 1992. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J. Biol. Chem. 267: 2234-2239.
66. Noelken ME, Nelson CA, Buckley CEI, Tanford C. 1965. Gross conformation of rabbit 7 S γ-immunoglobulin and its papain-cleaved fragments. J. Biol. Chem. 240: 218-224.
67. Padlan EA. 1994. Anatomy of the antibody molecule. Mol. Immunol. 31: 169-217.
68. Perosa F, Luccarelli G, Neri M, Dammacco F. 1997. The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant. J. Immunol. Meth. 203: 153-155.
69. Pokkuluri PR, Solomon A, Weiss DT, Stevens FJ, Schiffer M. 1999. Tertiary structure of human lambda 6 light chains. Amyloid. 6: 165-171.
70. Poljak RJ, Amzel LM, Avey HP, Chen BL, Phizackerly RP, Saul F. 1973. Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2.8 Å resolution. Proc. Natl. Acad. Sci. USA 70: 3305-3310.
71. Poljak RJ, Amzel LM, Chen BL, Phizackerly RP, Saul F. 1974. The three-dimensional structure of the Fab' fragment of a human myeloma immunoglobulin at 2.0 Å resolution. Proc. Natl. Acad. Sci. USA 71: 3440-3444.
72. Qi M, Steiger G, Schifferli JA. 1992. A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG. J. Immunol. 149: 2345-2351.
73. Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD. 2001. The structure of a human type III Fcgamma receptor in complex with Fc. J. Biol. Chem. 276: 16469-16477.
74. Rajan SS, Ely KR, Abola EE, Wood MK, Colman PM, Athay RJ, Edmundson AB. 1983. Three-dimensional structure of the Mcg IgG1 immunoglobulin. Mol. Immunol. 20: 787-799.
75. Ramsland PA, Shan L, Moomaw CR, Slaughter CA, Fan Z-C, Guddat LW, Edmundson AB. 2000. An unusual human IgM antibody with a protruding HCDR3 and high avidity for its peptide ligands. Mol. Immunol. 37: 295-310.
76. Ramsland PA, Kaushik A, Marchalonis JJ, Edmundson AB. 2001a. Incorporation of long CDR3s into V domains: Implications for the structural evolution of the antibody-combining site. Exp. Clin. Immunogenet. 18: 176-198.
77. Ramsland PA, Upshaw JL, Shultz BB, DeWitt CR, Chissoe III WF, Raison RL, Edmundson AB. 2001b. Interconversion of different crystal forms of Fabs from human IgM cryoglobulins. J. Cryst. Growth 232: 204-214.
78. Riechmann L, Clark M, Waldmann H, Winter G. 1988. Reshaping human antibodies for therapy. Nature 332: 323-327.
79. Rini JM, Stanfield RL, Stura EA, Salinas PA, Profy AT, Wilson IA. 1993. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. USA 90: 6325-6329.
80. Routledge EG, Falconer ME, Pope H, Lloyd IS, Waldmann H. 1995. The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody. Transplantation 60: 847-853.
81. Ruiz M, Lefranc MP. 2002. IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics 53: 857-883.
82. Ruiz M, Giudicelli V, Ginestoux C, Stoehr P, Robinson J, Bodmer J, Marsh SG, Bontrop R, Lemaitre M, Lefranc G, Chaume D, Lefranc MP. 2000. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 28: 219-221.
83. Saphire EO, Parren PW, Barbas CF 3rd, Burton DR, Wilson IA. 2001a. Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: An antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallogr. D57: 168-171.
84. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. 2001b. Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design. Science 293: 1155-1159.
85. Schiffer M, Hardman KD, Wood MK, Edmundson AB, Hook ME, Ely KR, Deutsch HF. 1970. A preliminary crystallographic investigation of a human L-type Bence-Jones protein. J. Biol. Chem. 245: 728-730.
86. Schiffer M, Girling RL, Ely KR, Edmundson AB. 1973. Structure of a λ-type Bence-Jones protein at 3.5 Å resolution. Biochemistry 12: 4620-4631.
87. Segal DM, Padlan EA, Cohen GH, Rudikoff S, Potter M, Davies DR. 1974. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA 71: 4298-4302.
88. Shan L, Guddat LW, Raison RL, Edmundson AB. 1993. Crystallization of an Fv fragment from a human IgM cryoglobulin by a microseeding technique. J. Crystallogr. Growth 126: 229-244.
89. Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel BC, Davies DR. 1987. Three-dimensional structure of an antibody-antigen complex. Proc. Natl. Acad. Sci. USA 84: 8075-8079.
90. Shirai H, Kidera A, Nakamura H. 1996. Structural classification of CDR-H3 in antibodies. FEBS Lett. 399: 1-8.
91. Silverton EW, Navia MA, Davies DR. 1977. Three-dimensional structure of an intact human immunoglobulin. Proc. Natl. Acad. Sci. USA 74: 5140-5144.
92. Soderlind E, Simonsson AC, Borrebaeck CA. 1992. Phage display technology in antibody engineering: Design of phagemid vectors and in vitro maturation systems. Immunol. Rev. 130: 109-124.
93. Soderlind E, Carlsson R, Borrebaeck CA, Ohlin M. 2001. The immune diversity in a test tube - Non-immunised antibody libraries and functional variability in defined protein scaffolds. Comb. Chem. High Throughput Screen. 4: 409-416.
94. Sohi MK, Sutton BJ, Corper AL, Wan T, Ravinder MN, Brown C, Rijnders T, Beale D, Feinstein A, Humphreys AS, Taussig MJ. 1994. Crystallization and preliminary X-ray analysis of the Fab fragment of a human monoclonal IgM rheumatoid factor (2A2). J. Mol. Biol. 242: 706-708.
95. Sohi MK, Corper AL, Wan T, Steinitz M, Jefferis R, Beale D, He M, Feinstein A, Sutton BJ, Taussig MJ. 1996. Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4. Immunology 88: 636-641.
96. Spiegel PC Jr, Jacquemin M, Saint-Remy JM, Stoddard BL, Pratt KP. 2001. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: Identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 98: 13-19.
97. Stanfield RL, Fieser TM, Lerner RA, Wilson IA. 1990. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248: 712-719.
98. H domains of immunoglobulins. J. Mol. Biol. 215: 175-182.
99. van Dijk MA, van de Winkel JG. 2001. Human antibodies as next generation therapeutics. Curr. Opin. Chem. Biol. 5: 368-374.
100. Vaughan TJ, Osbourn JK, Tempest PR. 1998. Human antibodies by design. Nat. Biotechnol. 16: 535-539.
101. Weber RJ, Clem LW. 1981. The molecular mechanism of cryoprecipitation and cold agglutination of an IgM lambda Waldenstrom macroglobulin with anti-Gd specificity; sedimentation analysis and localization of interacting sites. J. Immunol. 127: 300-305.
102. Winter G, Milstein C. 1991. Man-made antibodies. Nature 349: 293-299.